PANOVA-3 study showed significant OS improvement with tumor-treating fields plus chemotherapy in pancreatic cancer patients. Median OS was 16.2 months with combination therapy versus 14.16 months with ...

AstraZeneca AZN has announced positive results from the phase III CAPItello-281 study, which evaluated a combination regimen involving its ATK inhibitor Truqap (capivasertib) in certain patients with ...

A college degree is supposed to be the great equalizer in the labor market, promising upward mobility and better pay for all. But a new study published in the Journal of Applied Psychology suggests ...

A recent study in the Journal of Nutrition Education and Behavior evaluated the feasibility of Nutri, a user-centered digital platform designed to support personalized, evidence-based diet goal ...

The LIBERTY-CUPID C study enrolled CSU patients aged six years and older who remained symptomatic despite standard-of-care (SOC) antihistamines and were not previously treated with Novartis ...

In recognition of Women’s History Month in March, Fidelity Investments has released new findings on the financial status of women, strategies to reduce financial anxiety and how parents are preparing ...

Learning to 'let go' of dreams that are unattainable may help you feel more satisfied in your relationship if your partner snores like a lumber mill. While this may seem like a random connection, ...

AbbVie ABBV announced positive top-line results from the pivotal phase III TEMPO-2 study, which evaluated its recently acquired investigational drug tavapadon in adults with early Parkinson’s disease ...

Sanofi SA (NASDAQ:SNY) on Tuesday shared progress from its mid- to late-stage respiratory pipeline. The French drug maker reported preliminary results from the TIDE-Asthma phase 2 study of amlitelimab ...

Addressing climate change is not only a hot topic in Hollywood, it is also a growing focus of government regulatory agencies, with the Security & Exchange starting in 2024 to require publicly traded ...